NCT04482244View on ClinicalTrials.gov

RCT of CBD for Anxiety in Advanced Breast Cancer

PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

January 19, 2022

Primary Completion Date

March 1, 2023

Study Completion Date

December 1, 2026

Conditions

Advanced Breast CancerAnxietyCBD

Interventions

DRUG

Cannabidiol

Liquid taken orally

OTHER

Placebo

Liquid taken orally

Trial Locations (1)

02115

Dana Farber Cancer Institute, Boston

All Listed Sponsors

collaborator

Hans and Mavis Lopater Foundation

UNKNOWN

lead

Dana-Farber Cancer Institute

OTHER